-
Committee Chair Says DePuy Deserves Criminal Investigation
Reports recently released by DePuy allegedly shows that their metal-on-metal hip implants failed after two and half years. The Telegraph also revealed they continued to market the implant after a surgeon warned the executive of manufacturing about painful symptoms patients were experiencing. The surgeon said they were suspected for putting metal ions into the bloodstream, […]
-
DePuy Executive Asked Why Plans to Re-Design ASR Hip Halted
The president of the orthopedic division of Johnson & Johnson, Andrew Ekdahl, said the company recalled their all-metal implant due to it not meeting “clinical needs for the product.” He testified at a trial recently due to claims the company failed to issue warnings about the risks involved with the implants. He was questioned by […]
-
Executive’s Involvement with Defective Hip Implant Questioned
A new executive was hired to lead Johnson & Johnson’s orthopedics division after the company’s artificial hip implants were recalled in an effort to help clear their image. However, the executive who was hired knew about the defects three years before the implants were recalled and supervised the introduction of the implant in the US. […]
-
Witness Testimony Says J&J Altered Safety Tests
While designing the all-metal hip implant, Johnson & Johnson failed safety tests they set forth, according to witness testimony, then altered the protocol rather than fixing the flaw itself. Loren Kransky is suing them for defects involved with their metal hip implants. Johnson & Johnson recalled 93,000 ASR hips in 2010 when they announced that […]
-
Opening Statements Heard in DePuy Hip Trial
During opening statements on Friday against Johnson & Johnson, they were aware their metal-on-metal hip implants were defective when they started selling them in 2004. So far, there have been over 10,000 lawsuits filed against the company, whose hip implants were found to fail at a much higher rate. The first personal injury trial against […]
-
Pradaxa Recalled for Stroke Risk
Today, Berhringer Ingelheim Pharmaceuticals announced a recall of Pradaxa with an expiration of January 15, 2015. There is a risk of stroke and systemic embolism for those with non-valvular artrial fibrillation. One particular lot number is involved in this recall. A packaging defect resulted in the recall. Moisture might get into a bottle due to […]
-
Move Over Laws for Maryland, Virginia, DC
A digest of motor laws was published by AAA to show motorists what you must do when an emergency vehicle is approaching. In Maryland, if you see an emergency vehicle stopped in a lane in your direction of traffic, with their lights flashing, you must change into a lane that is not directly next to […]
-
Johnson & Johnson Faces Thousands of Lawsuits
During the first settlements for the case against Johnson & Johnson, who face over 8,000 lawsuits for recalled hip implants, they paid around $600,000 to resolve those cases. Another case involving a Nevada resident who sued the company was settled recently and the company will pay $200,000 for that case. They negotiated at a “low […]
-
Stryker Recalls Implant for Causing Pain, Immobility
Stryker recently conducted a recall of the Stryker Rejuvenate implant because they may result in tissue damage from metal corrosion, which may cause symptoms such as swelling, immobility, pain, and premature loosening. Other companies have gone under fire for their products, which were found to have a high rate of failure. The DePuy ASP and […]
-
Identity Theft Amongst Seniors Rising
The US Department of Justice’s Bureau of Justice Statistics recently released data that shows identity theft is a rising epidemic amongst senior citizens ages 50 or older. Over 3.5 million homes were affected by identity theft, including two types: scams via telephone or medical fraud. They are advising seniors to remain cautious of telemarketers and […]